Yüklüyor......
The Effect of Nintedanib on T-Cell Activation, Subsets and Functions
BACKGROUND: T cells are important regulators of inflammation and, via release of mediators, can contribute to pulmonary fibrosis. Nintedanib is approved for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease (ILD) and chronic fibrosing ILDs with a...
Kaydedildi:
| Yayımlandı: | Drug Des Devel Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7954282/ https://ncbi.nlm.nih.gov/pubmed/33727792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S288369 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|